Thus, Imaging-Community-AMARETTO (Appendix Fig A1) identified THBS1 and MAP2 as novel master drivers across the three STAT3, AHR, CCR2, and OLIG2 communities that provide new insights into how these distinct key mechanisms are linked in glioma. The gene discussed is MAP2; the disease is central nervous system cancer.